Moderna, Inc. - Common Stock (MRNA)
28.14
+3.44 (13.93%)
NASDAQ · Last Trade: Oct 31st, 1:37 AM EDT
October 30, 2025 – While the broader S&P 500 Healthcare sector navigated a day of mixed to negative performance, a singular beacon of optimism emerged from the biotechnology landscape today as Moderna (NASDAQ: MRNA) witnessed an extraordinary surge in its stock price. Shares of the mRNA vaccine pioneer jumped by
Via MarketMinute · October 30, 2025
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · October 30, 2025
According to a report from Seeking Alpha, citing Stat News, Moderna has held talks with at least one large drugmaker. 
Via Stocktwits · October 30, 2025
Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · October 30, 2025
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. 
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds. 
Via StockStory · October 30, 2025
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session.
Via Chartmill · October 28, 2025
As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the market. While specific daily performance metrics remain unreleased, today's trading likely saw the sector reacting to a
Via MarketMinute · October 27, 2025
New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares plummeting a staggering 31.4%. The significant sell-off came despite the company reporting strong third-quarter 2025 earnings that largely met or exceeded
Via MarketMinute · October 23, 2025
Moderna ends its CMV vaccine program after a Phase 3 trial failed to meet efficacy goals, but maintains its 2028 breakeven and financial guidance.
Via Benzinga · October 23, 2025
The company is scrapping its study in congenital CMV after the vaccine proved just 6% to 23% effective.
Via Investor's Business Daily · October 23, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
Via Chartmill · October 23, 2025
The biotech will continue testing the vaccine in bone marrow transplant patients, where CMV reactivation can cause serious complications, and said no safety concerns were identified.
Via Stocktwits · October 23, 2025
Washington D.C., October 22, 2025 – The world stands at a critical juncture as the 2025 Economic Freedom of the World index, prominently released by the Fraser Institute in collaboration with the Cato Institute, reveals an alarming and unprecedented trend: a decline in global economic freedom for four consecutive years.
Via MarketMinute · October 22, 2025
Discover the top S&P500 movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · October 22, 2025
The biotech's innovative qualities will come in handy.
Via The Motley Fool · October 22, 2025
Shares could keep sliding, as Moderna's post-COVID pipeline has yet to reach a breakthrough.
Via The Motley Fool · October 22, 2025
DataVault AI and Wellgistics Health are collaborating to bring blockchain technology to the US prescription drug market.
Via Benzinga · October 22, 2025
Don't try to catch a falling surgical knife.
Via The Motley Fool · October 21, 2025
U.S. stocks rise on Monday, with the Dow up 500+ points. Moderna and Cleveland-Cliffs report gains. Most S&P sectors close higher, with Fear & Greed Index at 30.3.
Via Benzinga · October 21, 2025
Via Benzinga · October 20, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.
Via Chartmill · October 20, 2025
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via Chartmill · October 20, 2025
U.S. stock futures rose on Monday following Friday’s advances. Futures of major benchmark indices were higher.
Via Benzinga · October 20, 2025